Tele: 561.316.3330
Breaking Medical Device News

Sunday, October 17, 2021
HomeAmbuAmbu Awarded National Single-Use Endoscopy Contract with Premier Inc.

Ambu Awarded National Single-Use Endoscopy Contract with Premier Inc.

August 28, 2020:  Today Ambu Inc., announced today that it has been awarded a single-use endoscopy contract in the category of Surgical Disposable Scopes with Premier Inc., one of the largest performance improvement alliances of hospitals and healthcare systems in the U.S. In addition, Ambu was the only supplier of single-use endoscopes designated to participate in Premier’s SURPASS and ASCEND purchasing programs.

The three-year agreement creates a single-use endoscopy category specifically for the Premier membership and was signed this week, effective November 1, 2020. The partnership with Premier – whose members represent 4,100 hospital and health systems in the U.S. and 200,000 other providers – will further accelerate Ambu’s rapidly expanding share of the single-use endoscope market by giving those accounts pre-negotiated pricing and terms for Ambu’s full suite of endoscopy products.

Premier’s SURPASSTM program represents $8.4 billion in annual supply chain purchasing, with more than 30,000 acute care beds across 24 states and two U.S. territories. The ASCEND group purchasing program, meanwhile, is one of the nation’s largest committed purchasing programs with more than 120,000 acute care beds and a combined purchasing volume of more than $18 billion.

Boosting Ambu’s market share

Ninety-six percent of the top 500 bronchoscopy accounts in the U.S. are already using Ambu’s sterile, single-use bronchoscopes in the OR and ICU. Over the past twelve months, Ambu has increased its market share in these accounts and across all US hospitals, as the market continues to transition to single-use bronchoscopy.
This partnership with Premier will further boost Ambu’s market share by giving more accounts access to its full suite of single-use endoscopy products.

“The agreement allows Ambu to tap into a vast market of hospitals, health systems and healthcare providers across the U.S. with our single-use endoscopes,” said Juan Jose Gonzalez, CEO of Ambu A/S. “It strengthens our position in the U.S. and demonstrates the value of our portfolio in improving workflows and increasing patient safety. Premier is an exceptional company that we have known for years and we look forward to continue building our relationship with a company that is transforming the healthcare industry.”

Premier is highly regarded for its work driving efficiencies in hospitals and healthcare systems. Over the years, it has developed an alliance of more than 4,100 U.S. hospitals and health systems and over 200,000 other providers and organizations.

Ambu launched the world’s first single-use flexible bronchoscope, the Ambu® aScopeTM in 2009. In 2019, over 600,000 Ambu single-use endoscopes were used in more than 6,000 hospitals making Ambu the world’s largest supplier of single-use endoscopes. In 2020, Ambu expects to sell over 1 million single-use endoscopes.

Ambu received 510(k) clearance from the U.S. Food and Drug Administration in July 2020 for its single-use aScopeTM Duodeno, and the FDA cleared Ambu’s aScopeTM 4 Cysto in April 2020. By 2022, Ambu plans to introduce another 12 new devices across all major areas of endoscopy, including GI, the largest endoscopy market globally.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy